0001104659-23-077174.txt : 20230630
0001104659-23-077174.hdr.sgml : 20230630
20230630163632
ACCESSION NUMBER: 0001104659-23-077174
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230628
FILED AS OF DATE: 20230630
DATE AS OF CHANGE: 20230630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilmore Geoffrey
CENTRAL INDEX KEY: 0001429407
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36464
FILM NUMBER: 231062295
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS
STREET 2: 6 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGILE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001261249
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 COLLEGE ROAD EAST
STREET 2: SUITE 310
CITY: PRINCETON
STATE: NJ
ZIP: 08540-6635
BUSINESS PHONE: 609-683-1880
MAIL ADDRESS:
STREET 1: 500 COLLEGE ROAD EAST
STREET 2: SUITE 310
CITY: PRINCETON
STATE: NJ
ZIP: 08540-6635
4
1
tm2320328-1_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-28
0
0001261249
AGILE THERAPEUTICS INC
AGRX
0001429407
Gilmore Geoffrey
500 COLLEGE ROAD EAST, SUITE 310
PRINCETON
NJ
08540
0
1
0
0
Chief Administrative Officer
0
Common Stock
2023-06-28
4
A
0
13500
0
A
13540
D
Common Stock
2023-06-28
4
A
0
6716
0
A
20256
D
Employee Stock Option (Right to Buy)
2.48
2023-06-28
4
A
0
4500
0
A
2033-06-27
Common Stock
4500
4500
D
These shares represent restricted stock units ("RSUs") which were granted on June 28, 2023. The RSUs will vest in four equal installments over four years upon the anniversary of the grant, such that the RSUs will be fully vested on June 28, 2027.
On April 10, 2023, the Issuer completed a one-for-fifty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split.
These shares represent RSUs that were granted on June 28, 2023, which will vest and be settled in common stock on June 28, 2024.
This option was granted on June 28, 2023. 25% of the shares subject to the stock option vest on June 28, 2024, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on June 28, 2027.
/s/ Geoffrey P. Gilmore
2023-06-30